文献速递前列腺癌

前列腺穿刺活检中的炎症与较低前列腺癌风险相关:一项荟萃分析

Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis.
PubMed 文献 · J Urol · 2017-12-12

该荟萃分析检索1990至2016年文献,纳入25项队列或病例对照研究共20,585名受试者(其中6,641例前列腺癌),评估前列腺穿刺活检组织学炎症与前列腺癌风险的关系。结果显示任何炎症与较低前列腺癌风险显著相关(OR 0.455,95%CI 0.337-0.573),急性和慢性炎症亚组亦分别相关(OR 0.681,95%CI 0.450-0.913;OR 0.499,95%CI 0.334-0.665)。

要点

  • 前列腺穿刺活检存在任何炎症与较低前列腺癌风险显著相关(OR 0.455,95%CI 0.337-0.573)。
  • 急性炎症(4项研究)与较低风险相关(OR 0.681,95%CI 0.450-0.913)。
  • 慢性炎症(15项研究)与较低风险相关(OR 0.499,95%CI 0.334-0.665)。

核心结论

  • 在25项研究的荟萃分析中,前列腺穿刺活检上的炎症与较低的前列腺癌风险相关。
  • 临床上前列腺穿刺活检存在炎症可能降低后续前列腺癌诊断的风险。

研究设计与样本

  • 检索Embase、PubMed和Web of Science自1990年1月1日至2016年10月1日的摘要,关键词为前列腺癌、炎症和活检。
  • 纳入标准为原创研究、成年人类受试者、队列或病例对照设计、前列腺穿刺活检组织学炎症及组织学前列腺癌。
  • 共检索到1,030篇摘要,46篇全文审阅,最终25项研究纳入分析,合计20,585名受试者,其中6,641例前列腺癌患者。

主要发现

  • 研究间存在显著异质性(I2=84.4%,p<0.001)。
  • 25项研究中任何炎症的存在与较低前列腺癌风险显著相关(OR 0.455,95%CI 0.337-0.573)。
  • 无发表偏倚证据(p>0.05)。
  • 按炎症类型亚组分析,4项研究中急性炎症与较低前列腺癌风险相关(OR 0.681,95%CI 0.450-0.913)。
  • 15项研究中慢性炎症与较低前列腺癌风险相关(OR 0.499,95%CI 0.334-0.665)。

关键数值与推荐

  • 任何炎症 vs 无炎症:OR 0.455(95%CI 0.337-0.573),与较低前列腺癌风险相关。
  • 急性炎症:OR 0.681(95%CI 0.450-0.913),与较低前列腺癌风险相关。
  • 慢性炎症:OR 0.499(95%CI 0.334-0.665),与较低前列腺癌风险相关。
  • 异质性:I2=84.4%,p<0.001。
  • 发表偏倚:p>0.05(无证据)。

临床怎么用

  • 前列腺穿刺活检显示炎症时,可能提示后续前列腺癌诊断风险较低。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We performed a comprehensive literature review and meta-analysis to evaluate the association of inflammation on prostate needle biopsies and prostate cancer risk. MATERIALS AND METHODS: We searched Embase®, PubMed® and Web of Science™ from January 1, 1990 to October 1, 2016 for abstracts containing the key words prostate cancer, inflammation and biopsy. Study inclusion criteria were original research, adult human subjects, cohort or case-control study design, histological inflammation on prostate needle biopsy and prostate cancer on histology. Two independent teams reviewed abstracts and extracted data from the selected manuscripts. Combined ORs and 95% CIs of any, acute and chronic inflammation were calculated using the random effects method. RESULTS: Of the 1,030 retrieved abstracts 46 underwent full text review and 25 were included in the final analysis, comprising a total of 20,585 subjects and 6,641 patients with prostate cancer. There was significant heterogeneity among studies (I2 = 84.4%, p <0.001). The presence of any inflammation was significantly associated with a lower prostate cancer risk in 25 studies (OR 0.455, 95% CI 0.337-0.573). There was no evidence of publication bias (p >0.05). When subanalyzed by inflammation type, acute inflammation in 4 studies and chronic inflammation in 15 were each associated with a lower prostate cancer risk (OR 0.681, 95% CI 0.450-0.913 and OR 0.499, 95% CI 0.334-0.665, respectively). CONCLUSIONS: In a meta-analysis of 25 studies inflammation on prostate needle biopsy was associated with a lower prostate cancer risk. Clinically the presence of inflammation on prostate needle biopsy may lower the risk of a subsequent prostate cancer diagnosis.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Vasavada SR, Dobbs RW, Kajdacsy-Balla AA, et al. Inflammation on Prostate Needle Biopsy is Associated with Lower Prostate Cancer Risk: A Meta-Analysis. J Urol. 2017. PMID: 29246732. doi:10.1016/j.juro.2017.11.120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。